Acuña M, Eaton L, Cifuentes L, Massardo D
Genetics Program ICBM, Faculty of Medicine, University of Chile, Santiago, Chile.
Br J Clin Pharmacol. 2006 Jun;61(6):778-82. doi: 10.1111/j.1365-2125.2006.02595.x.
Thymidylate synthase (TYMS) is an important target enzyme for the fluoropyrimidines. The TYMS gene enhancer region possesses tandemly repeated (TSER) sequences that are polymorphic in humans and different among ethnic groups. The aims of this study were to estimate the frequencies of the TSER variants in two hospital samples located in the northern (HSJ) and eastern (CLC) parts of Santiago, Chile, and compare them with the frequencies in other populations of different ethnic origin.
Genotyping of TSER variants in 368 Chilean subjects (HSJ = 178 and CLC = 190) by polymerase chain reaction; products of amplification were electrophoresed, obtaining fragments of 250 bp for allele TSER3 and 220 bp for allele TSER2.
The two hospital samples had different degrees of Amerindian admixture (HSJ 34.5%; CLC 15.9%), which was not reflected in the observed frequencies of the CLC TSER3: 56.8% and HSJ TSER3: 53.4%.
Our results are unexpected, considering that genetic markers in the Chilean population generally show allele frequencies between those observed in European Caucasians and Amerindians and that the percentage of Amerindian admixture in CLC is lower than in HSJ. Both hospitals should have had greater frequencies of TSER*3 than were found and the frequency should have been greater in HSJ than in CLC; the only logical explanation of our results is that the frequency of this allele in aboriginal Chilean people is much lower than the 80% estimated for Mongoloid populations.
胸苷酸合成酶(TYMS)是氟嘧啶类药物的重要靶酶。TYMS基因增强子区域存在串联重复(TSER)序列,该序列在人类中具有多态性,且在不同种族间存在差异。本研究的目的是估计位于智利圣地亚哥北部(HSJ)和东部(CLC)的两家医院样本中TSER变异体的频率,并将其与其他不同种族人群的频率进行比较。
采用聚合酶链反应对368名智利受试者(HSJ = 178名,CLC = 190名)的TSER变异体进行基因分型;扩增产物进行电泳,等位基因TSER3获得250 bp的片段,等位基因TSER2获得220 bp的片段。
两家医院样本的美洲印第安人混合程度不同(HSJ为34.5%;CLC为15.9%),但在观察到的CLC的TSER3频率(56.8%)和HSJ的TSER3频率(53.4%)中未体现出来。
考虑到智利人群中的遗传标记通常显示出介于欧洲白种人和美洲印第安人之间的等位基因频率,且CLC中美洲印第安人混合的百分比低于HSJ,我们的结果出乎意料。两家医院的TSER*3频率都应高于所发现的频率,且HSJ的频率应高于CLC;对我们结果的唯一合理的解释是,该等位基因在智利原住民中的频率远低于对蒙古人种人群估计的80%。